Biodesix (BDSX) vs Burning Rock Biotech (BNR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Biodesix (BDSX) has outperformed Burning Rock Biotech (BNR) over the past year, gaining 261.9% versus a gain of 68.4%. Over five years, BDSX leads with a -82.4% price change compared with -89.4% for BNR. Biodesix is the larger company by market cap ($270.4 million vs $160.3 million), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDSX | BNR |
|---|---|---|
| Share price | $25.63 | $15.20 |
| Market cap | $270.43M | $160.30M |
| 1-day change | -2.99% | +0.13% |
| YTD return | +288.53% | -24.67% |
| 1-year return | +261.92% | +68.40% |
| 5-year return | -82.39% | -89.43% |
| EPS (TTM) | $-3.10 | $-0.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.97 | $41.72 |
| 52-week low | $5.26 | $6.79 |
| Distance from 52-week high | -19.83% | -63.57% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +45.65% | — |
| Average volume | 100.74K | 28.77K |
| Shares outstanding | 10.55M | 8.81M |
| Employees | 334 | 667 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BDSX has outperformed BNR by 193.5 percentage points over the past year.
About Biodesix
BDSX stock →Biodesix, Inc. operates as a diagnostic solutions company.
Health Care · Medical Specialities · 334 employees
About Burning Rock Biotech
BNR stock →Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Health Care · Medical Specialities · 667 employees
BDSX vs BNR FAQ
Which is bigger, Biodesix or Burning Rock Biotech?
Biodesix (BDSX) is larger, with a market capitalization of $270.43M compared with $160.30M for Burning Rock Biotech (BNR).
Which stock has performed better over the past year, BDSX or BNR?
BDSX returned +261.92% over the past 12 months, compared with +68.40% for BNR (price return, excluding dividends). Past performance does not predict future results.
Are Biodesix and Burning Rock Biotech in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.